Insider Trading History of Pande Atul

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Pande Atul since 2019. This trader's CIK number is 1643071. At the time of last reporting, Pande Atul was the Director of Immunovant, Inc.. (stock ticker symbol IMVT). Also see all insider trading activities at Immunovant, Inc..

Note that in the past Pande Atul also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Immunovant, Inc. (IMVT) by Pande Atul

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 IMVT 0 $0 7,750 $221,185 0 $0
2023 IMVT 0 $0 12,350 $490,208 0 $0
2021 IMVT 5,000 $39,900 0 $0 0 $0

Yearly summary of insider trading at Sio Gene Therapies Inc. (SIOX) by Pande Atul

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 SIOX 30,000 $68,530 0 $0 0 $0
2019 SIOX 3,370 $17,594 0 $0 0 $0

Yearly summary of insider trading at Karuna Therapeutics, Inc. (KRTX) by Pande Atul

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 KRTX 0 $0 5,000 $603,100 5,000 $80,000
2021 KRTX 0 $0 22,500 $2,682,899 22,500 $360,000
2020 KRTX 0 $0 40,714 $3,657,044 40,714 $118,884


Insider trading activities at 3 companies by Pande Atul:

1. Immunovant, Inc. (IMVT)

2. Sio Gene Therapies Inc. (SIOX)

3. Karuna Therapeutics, Inc. (KRTX)

Table 1. Insider trading of Immunovant, Inc. (IMVT) by Pande Atul

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-12-02 IMVT Sale 7,750 28.54 221,185
2023-12-01 IMVT Sale 12,350 39.69 490,208
2021-08-13 IMVT Buy 5,000 7.98 39,900

Table 2. Insider trading of Sio Gene Therapies Inc. (SIOX) by Pande Atul

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-11-24 SIOX Buy 10,000 2.34 23,400
2020-07-08 AXGT Buy 10,000 2.73 27,290
2020-03-16 AXGT Buy 10,000 1.78 17,840
2019-06-14 AXGT Buy 3,370 5.22 17,594

Table 3. Insider trading of Karuna Therapeutics, Inc. (KRTX) by Pande Atul

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-02-01 KRTX Option Ex 2,500 16.00 40,000
2022-02-01 KRTX Sale 2,500 110.80 277,000
2022-01-03 KRTX Sale 2,500 130.44 326,100
2022-01-03 KRTX Option Ex 2,500 16.00 40,000
2021-12-01 KRTX Option Ex 2,500 16.00 40,000
2021-12-01 KRTX Sale 2,500 127.73 319,325
2021-11-01 KRTX Sale 2,500 136.67 341,674
2021-11-01 KRTX Option Ex 2,500 16.00 40,000
2021-10-01 KRTX Option Ex 2,500 16.00 40,000
2021-10-01 KRTX Sale 2,500 120.72 301,800
2021-09-01 KRTX Option Ex 2,500 16.00 40,000
2021-09-01 KRTX Sale 2,500 117.82 294,550
2021-08-02 KRTX Option Ex 2,500 16.00 40,000
2021-08-02 KRTX Sale 2,500 114.17 285,425
2021-05-03 KRTX Sale 2,500 110.61 276,525
2021-05-03 KRTX Option Ex 2,500 16.00 40,000
2021-04-01 KRTX Sale 2,500 120.01 300,025
2021-04-01 KRTX Option Ex 2,500 16.00 40,000
2021-03-01 KRTX Sale 2,500 125.43 313,575
2021-03-01 KRTX Option Ex 2,500 16.00 40,000
2021-02-01 KRTX Option Ex 2,500 16.00 40,000
2021-02-01 KRTX Sale 2,500 100.00 250,000
2020-12-14 KRTX Option Ex 5,714 2.92 16,684
2020-12-14 KRTX Sale 5,714 92.64 529,344
2020-11-12 KRTX Sale 5,000 96.84 484,200
2020-11-12 KRTX Option Ex 5,000 2.92 14,600
2020-11-03 KRTX Option Ex 5,000 2.92 14,600
2020-11-03 KRTX Sale 5,000 85.00 425,000
2020-09-16 KRTX Option Ex 5,000 2.92 14,600
2020-09-16 KRTX Sale 5,000 85.00 425,000
2020-08-12 KRTX Sale 5,000 85.00 425,000
2020-08-12 KRTX Option Ex 5,000 2.92 14,600
2020-08-12 KRTX Sale 5,000 85.00 425,000
2020-08-12 KRTX Option Ex 5,000 2.92 14,600
2020-07-13 KRTX Option Ex 5,000 2.92 14,600
2020-07-13 KRTX Sale 5,000 95.43 477,150
2020-06-12 KRTX Option Ex 5,000 2.92 14,600
2020-06-12 KRTX Sale 5,000 93.27 466,350

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Pande Atul (Director of Immunovant, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.